Am J Addict. 2026 Feb 25. doi: 10.1111/ajad.70151. Online ahead of print.
ABSTRACT
BACKGROUND AND OBJECTIVES: Patients using fentanyl have worse treatment outcomes; however, little is known about other drugs that complicate treatment.
METHODS: A national survey (n = 396) was conducted using a random sample of clinicians waivered to prescribe buprenorphine in the United States. This study reports the results of a single survey item on clinicians’ perceptions of other drugs, besides IMF, complicating treatment.
RESULTS: Clinicians reported methamphetamine (86.4%), synthetic cannabinoids (42.7%), and xylazine (41.4%) were complicating treatment; reports varied by geographic region.
CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE: Rapid clinician surveys can provide real-time data on changing patterns of drug use’s impact treatment outcomes.
PMID:41741932 | DOI:10.1111/ajad.70151